Literature DB >> 30821649

Telephone-Delivered Cognitive Behavioural Therapy for Treating Symptoms of Anxiety and Depression in Parkinson's Disease: A Pilot Trial.

Viviana M Wuthrich1, Ronald M Rapee1.   

Abstract

Objectives: To determine the feasibility, acceptability and initial efficacy of telephone-delivered cognitive behavioral therapy (CBT) for the treatment of anxiety and depressive symptoms in people with Parkinson's disease.
Methods: A small randomized controlled trial compared telephone-based CBT to waitlist control. Eleven participants aged >50 years with Parkinson's disease and anxiety and/or depressive symptoms above recommended clinical cut-offs, were randomized to one of two conditions. Participants completed self-report measures of symptom severity and quality of life. Their carers were invited to participate and completed self-reported measures of symptoms and carer burden. At the end of the 10-week intervention period, participants and carers were reassessed on baseline measures, and again one month later.
Results: The CBT program was associated with significantly reduced depressive symptoms (Cohen's d = .90) at post-treatment with gains maintained at one-month follow-up. Anxiety symptom decreases (Cohen's d = 0.36) were not statistically different. Waitlist was associated with significantly worsened anxiety. Carer symptoms also reduced with CBT. No changes on quality of life were found. Good acceptability and feedback was received. Conclusions: Telephone-based CBT reduced symptoms of depression in participants with Parkinson's disease but not anxiety. Clinical Implications: Telephone-based CBT is a promising treatment option.

Entities:  

Keywords:  Parkinson’s disease; anxiety; cognitive behavioral therapy; depression; telehealth

Year:  2019        PMID: 30821649     DOI: 10.1080/07317115.2019.1580811

Source DB:  PubMed          Journal:  Clin Gerontol        ISSN: 0731-7115            Impact factor:   2.619


  6 in total

Review 1.  Lewy Body Degenerations as Neuropsychiatric Disorders.

Authors:  Jared T Hinkle; Gregory M Pontone
Journal:  Psychiatr Clin North Am       Date:  2020-04-08

Review 2.  Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Authors:  Stéphane Prange; Hélène Klinger; Chloé Laurencin; Teodor Danaila; Stéphane Thobois
Journal:  Drugs Aging       Date:  2022-06-16       Impact factor: 4.271

3.  Efficacy of Cognitive Behavioral Therapy on Mood Disorders, Sleep, Fatigue, and Quality of Life in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Fangyi Luo; Mengfei Ye; Tingting Lv; Baiqi Hu; Jiaqi Chen; Junwei Yan; Anzhe Wang; Feng Chen; Ziyi He; Zhinan Ding; Jian Zhang; Chao Qian; Zheng Liu
Journal:  Front Psychiatry       Date:  2021-12-13       Impact factor: 4.157

4.  Individually Tailored Internet-Based Cognitive-Behavioral Therapy for Daily Functioning in Patients with Parkinson's Disease: A Randomized Controlled Trial.

Authors:  Martin Kraepelien; Robert Schibbye; Kristoffer Månsson; Christopher Sundström; Sara Riggare; Gerhard Andersson; Nils Lindefors; Per Svenningsson; Viktor Kaldo
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

5.  Acceptability and Feasibility of a Mindfulness Intervention Delivered via Videoconferencing for People With Parkinson's.

Authors:  Angeliki Bogosian; Catherine S Hurt; John V Hindle; Lance M McCracken; Debora A Vasconcelos E Sa; Sandra Axell; Katy Tapper; Jemima Stevens; P Shashi Hirani; Marya Salhab; Wenrong Ye; Patricia Cubi-Molla
Journal:  J Geriatr Psychiatry Neurol       Date:  2021-01-28       Impact factor: 2.680

6.  More than Just a Brain Disorder: A Five-Point Manifesto for Psychological Care for People with Huntington's Disease.

Authors:  Nicolò Zarotti; Maria Dale; Fiona J R Eccles; Jane Simpson
Journal:  J Pers Med       Date:  2022-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.